Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU2-31P is a human gene classified as a pseudogene and is homologous to the U2 small nuclear RNA gene. U2 snRNA genes are involved in pre-mRNA splicing, functioning within the spliceosome complex, but RNU2-31P itself does not produce any functional RNA or protein and is not implicated in known regulatory or disease processes[1][3]. RNU2-31P lacks known protein product, characterized biological activity, and evidence of relevance for therapeutic intervention. It is best described as a genomic relic of the U2 snRNA gene family with no established function or clinical utility.
None (no mechanism because not targeted by drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U2 small nuclear 31, pseudogene (RNU2-31P).